Andrew Pecora
Vice President of Cancer Services and Chief Innovations Officer of the John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, US
About
Dr. Pecora currently serves as Vice President of Cancer Services and Chief Innovations Officer of the John Theurer Cancer Center at Hackensack University Medical Center and co-Managing Partner of the Northern New Jersey Cancer Center (NNJCC), which is a private physicians practice group affiliated with HUMC. Leading up to its merger with NeoStem, Dr. Pecora was the Chairman and Chief Executive Officer for Progenitor Cell Therapy, a client-based cell therapy services company supporting the development and commercialization of cellular therapies. He is also the co-Founder and Chief Scientific Officer of Amorcyte, Inc., a privately funded biotechnology company developing cell therapy products to treat cardiovascular disease. Dr. Pecora is a Professor of Medicine at the University of Medicine and Dentistry of New Jersey. He has authored or co-authored numerous articles, abstracts, books, chapters and monographs and is a frequent lecturer in the field of cancer. He received his Bachelor
Investment Focus
- Location
- Hackensack, US
Contact Information
Find more investors like Andrew
Search Investors